Literature DB >> 16423496

Comparison of real-time polymerase chain reaction using the Smart Cycler and the Gen-Probe amplified Mycobacterium tuberculosis direct test for detection of M. tuberculosis complex in clinical specimens.

June I Pounder1, Wade K Aldous, Gail L Woods.   

Abstract

The performance of a real-time polymerase chain reaction (PCR) assay using the Smart Cycler instrument and a minor groove binding MGB Eclipse probe (Epoch Biosciences, Bothell, WA) for identification of Mycobacterium tuberculosis complex in acid-fast bacillus smear-positive and smear-negative clinical specimens was assessed by comparing results to the Amplified M. tuberculosis Direct Test (MTD) and mycobacterial culture plus clinical diagnosis. After initial testing, the overall sensitivity, specificity, and positive and negative predictive values of PCR for the 172 specimens submitted for mycobacterial culture were 86.3%, 100%, 100%, and 94.5%, respectively. These same values for MTD were 98.0%, 99.2%, 98.0%, and 99.2%. For 83 additional specimens, only MTD and PCR were performed; 5 specimens were positive and 78 were negative by both tests. The sensitivity of the PCR assay was improved by using different primers and probes. The time to a result for real-time PCR, starting with a decontaminated sample, was less than 3 h compared with 5-6 h for the MTD.

Entities:  

Mesh:

Year:  2006        PMID: 16423496     DOI: 10.1016/j.diagmicrobio.2005.05.018

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  7 in total

1.  Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression.

Authors:  S Greco; M Rulli; E Girardi; C Piersimoni; C Saltini
Journal:  J Clin Microbiol       Date:  2009-01-14       Impact factor: 5.948

2.  Combined real-time PCR and rpoB gene pyrosequencing for rapid identification of Mycobacterium tuberculosis and determination of rifampin resistance directly in clinical specimens.

Authors:  Tanya A Halse; Justine Edwards; Phyllis L Cunningham; William J Wolfgang; Nellie B Dumas; Vincent E Escuyer; Kimberlee A Musser
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

3.  Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.

Authors:  Daphne I Ling; Laura L Flores; Lee W Riley; Madhukar Pai
Journal:  PLoS One       Date:  2008-02-06       Impact factor: 3.240

4.  Bronchoalveolar neutrophils, interferon gamma-inducible protein 10 and interleukin-7 in AIDS-associated tuberculosis.

Authors:  G S Kibiki; L C Myers; C F Kalambo; S B Hoang; M H Stoler; S E Stroup; E R Houpt
Journal:  Clin Exp Immunol       Date:  2007-02-07       Impact factor: 4.330

5.  Evaluation of the results of Mycobacterium tuberculosis direct test (MTD) and Mycobacterial culture in urine samples.

Authors:  Asli Gamze Sener; Nukhet Kurultay; Ilhan Afsar
Journal:  Braz J Microbiol       Date:  2008-12-01       Impact factor: 2.476

6.  Negative Mantoux test in a patient with definite pulmonary and ocular tuberculosis.

Authors:  Chen-Cheng Chao; Chun-Ju Lin; Huan-Sheng Chen; Tsung-Lin Lee
Journal:  Taiwan J Ophthalmol       Date:  2014-09-20

7.  Clinical Manifestations and Outcomes of Tubercular Uveitis in Taiwan-A Ten-Year Multicenter Retrospective Study.

Authors:  Chun-Ju Lin; Ning-Yi Hsia; De-Kuang Hwang; Yih-Shiou Hwang; Yo-Chen Chang; Yueh-Chang Lee; Yung-Ray Hsu; Po-Ting Yeh; Chang-Ping Lin; Hsi-Fu Chen; Wei-Chun Jan; Wei-Yu Chiang; Ming-Ling Tsai
Journal:  Medicina (Kaunas)       Date:  2022-03-03       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.